Company Monitoring Page for CRISPR-Therapeutics

latest headlines for company on cafepharma

Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Fierce Biotech
Fri, 06/9/23 - 10:07 am
Tags:
Vertex Pharmaceuticals, CRISPR Therapeutics, CRISPR, gene editing, FDA, sickle cell disease, beta thalassemia
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
Tags:
drug launches, AbbVie, Almirall, Apellis Pharmaceuticals, Astellas, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eli Lilly, Genmab, GSK, Iveric Bio, Pfizer, Roche, SAGE Therapeutics, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Vertex Pharmaceuticals
Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group
Yahoo/Reuters
Thu, 04/13/23 - 10:01 am
Tags:
Vertex Pharmaceutials, CRISPR Therapeutics, gene therapy, sickle cell disease, ICER
Gene Editing Therapeutics Could Hit the Market in 2023
BioSpace
Mon, 04/10/23 - 11:32 am
Tags:
gene editing, CRISPR Therapeutics, Vertex Pharmaceuticals, Intellia Therapeutics, Editas Medicine, Beam Therapeutics
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
Yahoo/Businesswire
Mon, 04/3/23 - 10:09 am
Tags:
Vertex Pharmaceuticals, CRISPR Therapeutics, sickle cell disease, beta thalassemia, FDA, exa-cel
Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality
Endpoints
Tue, 03/28/23 - 11:46 am
Tags:
Vertex Pharmaceuticals, diabetes, CRISPR, gene editing, CRISPR Therapeutics
CRISPR/ViaCyte and Genprex Vie for First Diabetes Gene Therapy
BioSpace
Mon, 03/13/23 - 10:21 am
Tags:
ViaCyte, CRISPR Therapeutics, Genprex, diabetes, gene therapy
Medicaid, with planned payment pilot, girds for influx of pricey gene therapies
BioPharma Dive
Tue, 02/21/23 - 04:37 pm
Tags:
Medicaid, sickle cell disease, gene therapies, Bluebird Bio, Vertex Pharmaceuticals, CRISPR Therapeutics
EMA validates Vertex's CRISPR application, clearing barrier on road to landmark approval
Fierce Biotech
Thu, 01/26/23 - 10:53 am
Tags:
Vertex Pharmaceuticals, CRISPR Therapeutics, EMA, CRISPR, sickle cell disease, exa-cel
Two Aurinia execs are out — and CRISPR’s operations chief isn't far behind
Endpoints
Sun, 10/30/22 - 04:05 pm
Tags:
Aurinia Pharmaceuticals, CRISPR Therapeutics
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
Tags:
biopharma stocks, AbbVie, Alnylam, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eisai, Eli Lilly, GSK, Intellia Therapeutics, Regeneron, Roche, Sanofi, Sarepta Therapeutics
Vertex given green light to seek US approval of CRISPR-based therapy
BioPharma Dive
Wed, 09/28/22 - 12:01 am
Tags:
Vertex Pharmaceuticals, CRISPR, CRISPR Therapeutics, FDA, exa-cel, beta thalassemia, sickle cell disease
CRISPR Tx Drug Targeting CD70 Offers Early Hope for Difficult T Cell Lymphomas
BioSpace
Mon, 06/13/22 - 10:48 am
Tags:
CRISPR Therapeutics, clinical trials, CTX130, CAR-T, solid tumors, T-cell lymphoma
CRISPR Therapeutics’ CAR-T for Lymphoma Shows Early Promise
BioSpace
Thu, 05/12/22 - 10:42 pm
Tags:
CRISPR Therapeutics, CTX130, clinical trials, lymphoma, EHA
Record-breaking 2021 revenue shows there's more to Swiss biotech sector than Roche, Novartis
Fierce Biotech
Wed, 05/4/22 - 10:30 am
Tags:
biotech, Switzerland, Novartis, Roche, Sophia Genetics, CRISPR Therapeutics
Why CRISPR Therapeutics Stock Is Soaring Today
Motley Fool
Tue, 03/8/22 - 10:52 pm
Tags:
CRISPR Therapeutics
A big year for sickle cell
EP Vantage
Tue, 03/1/22 - 10:12 am
Tags:
sickle cell disease, Agios, mitapivat, CRISPR Therapeutics, CTX001, clinical trials
CRISPR, ViaCyte beat Vertex to the clinic with diabetes cell therapy that evades the immune system
Endpoints
Tue, 11/16/21 - 10:34 am
Tags:
CRISPR Therapeutics, ViaCyte, Vertex Pharmaceuticals, type 1 diabetes, cell therapy, gene editing
CRISPR touts new results as fresh questions surround 'off-the-shelf' CAR-T
BioPharma Dive
Tue, 10/12/21 - 11:40 pm
Tags:
cancer, cell therapy, CRISPR Therapeutics
CRISPR Therapeutics takes a swing at ALS gene editing in discovery deal with AAV upstart Capsida
Endpoints
Tue, 06/15/21 - 10:37 am
Tags:
CRISPR Therapeutics, ALS, gene editing, Capsida

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.